The Form 4 filing, a report of an insider's stock trades, was filed with the SEC on October 13, 2026. The sales took place on October 9, 2026, four days before the filing date.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-10-09 |
| Date of Latest Transaction | 2026-10-09 |
| Buy/Sell | sell |
| Transaction Count | 17 |
| Shares Transacted | 9,500 |
| Price | $544.94 |
| Total Transaction Value | $5,176,935.89 |
| Insider | |
| Ticker Symbol | UTHR |
| Company | UNITED THERAPEUTICS Corp |
| Insider Name | ROTHBLATT MARTINE A |
| Insider Title | Chairperson & CEO |
| Sector - Industry | Other - Unclassified |
| Holdings | |
| Total Shares Owned After Transaction | 324,443 |
| Position Size Change | 2.84% |
| Filing | |
| Filing Date | 2026-10-13 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
These were sales of UTHR shares, reported under SEC transaction code S. The 17 transactions are grouped in one filing for one insider.
What was the average price of the transaction?
The average sale price was $544.94 per share across the 17 transactions. The available details do not show a price for each separate sale.
How did this transaction affect the insider's holdings?
Martine A. Rothblatt sold 9,500 shares and reported owning 324,443 shares afterward. The shares sold made up 2.84% of the reported shares owned before the sales.
What's the total transaction value?
The total value was $5,176,935.89 for the 9,500 shares sold. This amount covers all 17 transactions reported together.
Are there any special circumstances around this transaction?
The available information points to a Rule 10b5-1 trading plan, which sets trading instructions in advance. The filing's footnote text was not provided, so it is unclear which of the 17 transactions the plan covers. When the plan was set up and its trading schedule are also unknown.
For research purposes only; not investment advice.